Strategic MAnagement to Improve CRT Using Multi-Site Pacing (SMART-MSP)

About this Study

We are doing this study to learn more about the safety and effectiveness of pacing features in the Boston Scientific Resonate pacemakers in patients with heart failure according to the device's approved labeling and after Food and Drug Administration approval of the device.

Sponsor Protocol ID:C1918
IRB Number:2018-0066
Closed for Enrollment
Early Phase 1
May 28, 2019
Eligibility Criteria
18 years old
Both Male and Female

Inclusion Criteria

  1. Subjects who are willing and capable of providing informed consent. 
  2. Subjects who are willing and capable of participating in all testing/visits associated with this clinical study at an approved clinical study center and at the intervals defined by this protocol.
  3. Subjects who are age 18 and above, or of legal age to give informed consent specific to state and national law.

Exclusion Criteria

  1. Subjects who are expected to receive a heart transplant during the 12 months course of the study. 
  2. Subjects with documented life expectancy of less than 12 months. 
  3. Women of childbearing potential who are pregnant or plan to become pregnant over the course of the clinical trial. Note: For patients with uncertain pregnancy status, pregnancy tests should have been performed per site’s standard clinical practice prior to CRT-D device implant. 
  4. Subjects who enrolled in any other concurrent study or registry, with the exception of mandatory national or governmental.

Categories Click category to view its trials.
Heart Health
Participating Locations
Grants Ferry - UMMC
Jackson Medical Mall - UMMC Clinics
Pavilion - UMMC
University Hospital - UMMC
Contact Information
Contact Name: Theresa Hickey Hutson
Phone Number: 601-815-8702
Principal Investigator:Takeki Suzuki
How to participate in our Clinical Trials